Five things for pharma marketers to know: Tuesday, January 26, 2021
Merck halts development of COVID-19 vaccines; Moderna’s vaccine effective against new variants; AstraZeneca’s leukemia drug found to be safe and effective.
Roundup
Five things for pharma marketers to know: Monday, January 25, 2021
New Biden plan aims to boost FEMA-run vaccination sites; FDA approves monthly HIV shots; many U.S. counties still considered COVID-19 “testing deserts.”
Five things for pharma marketers to know: Friday, January 22, 2021
Eli Lilly says its monoclonal antibody prevents COVID-19 infections; Russia’s Sputnik vaccine approved in UAE and Hungary; Northway Biotech sets up plant in Boston.
Five things for pharma marketers to know: Thursday, January 21, 2021
Biden proposes $1.9 trillion COVID-19 aid package; Eli Lilly boosts diversity pledge; tech companies work to create vaccination record system.
Five things for pharma marketers to know: Wednesday, January 20, 2021
Black Americans getting vaccinated at much lower rates; companies rush to develop new drugs to beat COVID-19 variants; remote care startup K Health raises $132 million.
Five things for pharma marketers to know: Tuesday, January 19, 2021
Biden proposes $1.9 trillion COVID-19 aid package; Eli Lilly boosts diversity pledge; tech companies work to create vaccination record system.
Five things for pharma marketers to know: Friday, January 15, 2021
Woodcock under consideration to lead FDA; Biden advisor expects slowdown in new vaccine plan; Accolade to buy telemedicine startup.
Five things for pharma marketers to know: Thursday, January 14, 2021
Johnson & Johnson to release COVID-19 vaccine trial data; Amgen pays $240 million for autoimmune therapy; Dollar General to pay employees to receive vaccine.
Five things for pharma marketers to know: Wednesday, January 13, 2021
HHS to begin gathering data on hospital vaccinations; Intarcia Therapeutics loses funding from Luxin Venture Capital Group; House Democrats test positive for COVID in riot’s wake.
Five things for pharma marketers to know: Tuesday, January 12, 2021
Eli Lilly drug shows promise in slowing cognitive decline; Japan discovers another COVID strain; Valo Health raises $190 million to develop AI platform.
Five things for pharma marketers to know: Monday, January 11, 2021
Arthritis drugs show promise in treating severely ill COVID-19 patients; Scorpion Therapeutics brings in $162 million in funding; UnitedHealth buys Change Healthcare
Five things for pharma marketers to know: Friday, January 8, 2021
Biopharma leaders denounce Capitol violence; Senate Democrats likely to push for health policy changes; Wednesday becomes deadliest day in pandemic
Five things for pharma marketers to know: Thursday, January 7, 2021
Walgreens to sell pharmacy wholesale unit to AmerisourceBergen; CDC says rate of vaccine allergic reaction is 11.1 per million; mice with progeria live longer in gene-editing study.
Five things for pharma marketers to know: Wednesday, January 6, 2021
Moderna anticipates production of 600 million vaccine doses in 2021; More coronavirus strains likely to emerge; Biogen to collaborate with ViGeneron on ophthalmic gene therapy.
Five things for pharma marketers to know: Tuesday, January 5, 2021
The U.S. distributes 4 million vaccine doses; Haven Health shuts down; FDA to review diabetes drug Teplizumab
Want to read more?
Please login or register first to view this content.
